TITLE

Palliation of Carcinoma of the Esophagus: Is There a Hope for Cure?

AUTHOR(S)
Lambert, René
PUB. DATE
August 1994
SOURCE
American Journal of Gastroenterology;Aug1994 Supplement, Vol. 89 Issue 8, pS27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses palliation of carcinoma of the esophagus. Elements of treatment in palliation; Prognosis of esophageal cancer; Pretreatment evaluation of the disease.
ACCESSION #
16092804

 

Related Articles

  • Advanced cancer patients' prognostic information preferences: a review. Innes, S.; Payne, S. // Palliative Medicine;Jan2009, Vol. 23 Issue 1, p29 

    Open communication in cancer care has gained increasing importance in recent years and diagnostic disclosure is now common place. However, there is a significant variability in the sharing of prognostic information. Information needs may vary significantly over the disease trajectory, and there...

  • An Auxetic structure configured as oesophageal stent with potential to be used for palliative treatment of oesophageal cancer; development and in vitro mechanical analysis. Ali, Murtaza; Rehman, Ihtesham // Journal of Materials Science: Materials in Medicine;Nov2011, Vol. 22 Issue 11, p2573 

    Oesophageal cancer is the ninth leading cause of malignant cancer death and its prognosis remains poor. Dysphagia which is an inability to swallow is a presenting symptom of oesophageal cancer and is indicative of incurability. The goal of this study was to design and manufacture an Auxetic...

  • Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue // PLoS ONE;10/5/2015, Vol. 10 Issue 10, p1 

    Introduction: Body composition has emerged as a prognostic factor in cancer patients. We investigated whether sarcopenia at diagnosis and loss of skeletal muscle during palliative chemotherapy were associated with survival in patients with pancreatic cancer. Methods: We retrospectively...

  • EARLY DETECTION OF CARCINOMA OF THE ESOPHAGUS. Lust, Franz J. // American Journal of Gastroenterology;Apr1962, Vol. 37 Issue 4, p433 

    Presents information on a study that examined the early detection of carcinoma of the esophagus. Importance of the diagnosis of the disease to the survival rate of patients with esophageal cancer; Use of roentgenographic examination in the identification of the location of cancer cells.

  • GP Clinical: The diagnosis of lung cancer. Lyn, Ethan // GP: General Practitioner;10/7/2005, p90 

    This article focuses on the diagnosis of lung cancer. Lung cancer kills more general practitioner patients than any other. Yet, perhaps because of its smoking-associated stigma, perhaps because of its reputation for a poor prognosis, it receives much less attention than other forms of...

  • Esophageal Cancer. Lightdale, Charles J. // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p20 

    Presents a guideline for managing esophageal cancer. Risk factors; Diagnosis; Screening and surveillance; Treatment.

  • pCLE shows real promise in DONT BIOPCE study. PEDERSEN, AMANDA // Medical Device Daily;5/11/2010, Vol. 14 Issue 90, p1 

    The article discusses the Detection of Neoplastic Tissue in Barrett's Esophagus with In Vivo Probebased Confocal Endomicroscopy (DONT BIOPCE) study presented by Prateek Sharma at Digestive Disease Week in New Orleans, Louisiana in May 2010. Researchers from the University of Kansas School of...

  • Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus. El-Serag, Hashem B.; Aguirre, Thomas V.; Davis, Stephanie; Kuebeler, Mark; Bhattacharyya, Achyut; Sampliner, Richard E. // American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1877 

    BACKGROUND AND AIMS: Esophageal acid exposure is important in the pathogenesis of Barrett's esophagus (BE), and possibly in the progression of BE to dysplasia and carcinoma. The aim of this study is to compare the development of dysplasia in BE patients treated with or without proton pump...

  • Quantitative Assessment of 99mTc-Depreotide Uptake in Oesophageal Cancer and Precursor Conditions and Its Reflection in Immunohistochemically Detected Somatostatin Receptors. Herlin, Gunnar; Lundell, Lars; Öst, Åke; Aspelin, Peter; Svensson, Leif; Axelsson, Rimma // Radiology Research & Practice;2012, p1 

    Background: Somatostatin receptors (SSTRs) are over-expressed in several tumors making it possible for imaging with labelled SSTR. A previous study showed feasibility to image oesophageal cancer with SSTR analogue 99mTc-depreotide. Purpose: (1) To investigate expression of the SSTRs in different...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics